Faster, Better Bioprocessing in 2020
Achieving effective manufacturing processes and sufficient capacity remains a top priority across a diversified biologic drug pipeline.
Can Policy Keep Pace with Science and Discoveries?
The promise of new therapies is tempered by the need for affordability, safety, and ethics.
Mapping a Route for Cell and Gene Therapy Process Development
While cell and gene therapies differ in many ways, some of the best practices for process development and validation are similar.
Choices for Climbing the Biopharma Career Ladder
With a positive employment market, some biopharma professionals explore options for career advancement.
Pharma Regulation to be Shaped by Pricing and Production Issues
Pressures on FDA will affect industry’s success in bringing new therapies to market.
Lyophilization Presents Complex Challenges
Temperature-sensitive biologics are lyophilized to preserve therapeutic viability, but the process presents complexities and challenges that are as yet not fully understood.
Single-Use Bioreactors: To Scale Up or Scale Out?
Industry experts debate the pros and cons of “going bigger” than the 2000-L industry norm in a single vessel.
Therapeutic Potential of Green, Synthesized Gold Nanoparticles
This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.
Getting to the Root of Quality Problems
Focusing on symptoms instead of root causes locks teams into a corrective, rather than preventive, mindset.
BioPharm International, January 2020 Issue (PDF)
Click the title above to open the BioPharm International January 2020 issue in an interactive PDF format.
